Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18118773 | 0.97 | KDM4E (0.32) | TSPOKDM4EATML3MBTL1 | |
| SCHEMBL22150968 | 0.95 | KDM4E (0.32) | HDAC4KDM4EATML3MBTL1 | |
| SCHEMBL15866648 | 0.95 | KDM4E (0.33) | HDAC4KDM4EATML3MBTL1 | |
| SCHEMBL17804750 | 0.95 | KDM4E (0.33) | HDAC4KDM4EATML3MBTL1 | |
| SCHEMBL24712308 | 0.94 | ESR1 (0.31) | — | |
| SCHEMBL17816624 | 0.94 | KDM4E (0.33) | HDAC4KDM4EATML3MBTL1 | |
| SCHEMBL24712718 | 0.94 | ESR1 (0.30) | — | |
| SCHEMBL24712207 | 0.94 | KDM4E (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL17742412 | 0.93 | KDM4E (0.33) | HDAC4KDM4EATML3MBTL1 | |
| SCHEMBL24712289 | 0.93 | ESR1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECH CO LTD (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-4101841-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | TRDMT1, TCF4, TRMT1 | TSPO 537/4885HDAC4 2996/4885KDM4E 1205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.